α,α-Dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol is an intermediate in the synthesis of 2-Hydroxy Imiquimod (A611515), which is shown to activate a toll-like receptor 7/8 Independent Cytokine, which can be used in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments.